Clinical Trial Update: The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating oral budesonide and rectal hydrocortisone for active ulcerative colitis was terminated; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• Budesonide (BUDESONIDE)
• hydrocortisone (rectal formulation) (hydrocortisone)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Inflammatory Bowel Disease, Ulcerative Colitis | Phase 2 | Status: TERMINATED | Results posted: 2013-05-13